133 related articles for article (PubMed ID: 15074899)
1. Client retention in the British Columbia Methadone Program, 1996-1999.
Anderson JF; Warren LD
Can J Public Health; 2004; 95(2):104-9. PubMed ID: 15074899
[TBL] [Abstract][Full Text] [Related]
2. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.
Nosyk B; Marsh DC; Sun H; Schechter MT; Anis AH
J Subst Abuse Treat; 2010 Jul; 39(1):22-31. PubMed ID: 20418051
[TBL] [Abstract][Full Text] [Related]
3. Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.
Sharif B; Nosyk B; Sun H; Marsh DC; Anis A
Subst Use Misuse; 2013 Jun; 48(8):671-82. PubMed ID: 23750776
[TBL] [Abstract][Full Text] [Related]
4. Methadone in provincial prisons in British Columbia.
Rothon DA
Can HIV AIDS Policy Law Newsl; 1997-1998 Winter; 3-4(4-1):27-31. PubMed ID: 11365288
[TBL] [Abstract][Full Text] [Related]
5. Retention in Georgia opioid substitution therapy program and associated factors.
Ruadze E; Todadze K
Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
[TBL] [Abstract][Full Text] [Related]
6. [Factors influencing the rate on retention to methadone maintenance treatment program among heroin addicts in Guizhou, China].
Liang T; Liu EW; Zhong H; Wang B; Shen LM; Wu ZL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):131-5. PubMed ID: 19565871
[TBL] [Abstract][Full Text] [Related]
7. J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study.
Cousins G; Boland F; Barry J; Lyons S; Keenan E; O'Driscoll D; Bennett K; Fahey T
Drug Alcohol Depend; 2017 Apr; 173():126-131. PubMed ID: 28232249
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
9. Methadone dosage and retention of patients in maintenance treatment.
Caplehorn JR; Bell J
Med J Aust; 1991 Feb; 154(3):195-9. PubMed ID: 1988793
[TBL] [Abstract][Full Text] [Related]
10. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
Schütz CG; Rapiti E; Vlahov D; Anthony JC
Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
[TBL] [Abstract][Full Text] [Related]
11. Correlates of retention on the South Australian Methadone Program 1981-91.
Gaughwin M; Solomon P; Ali R
Aust N Z J Public Health; 1998 Dec; 22(7):771-6. PubMed ID: 9889441
[TBL] [Abstract][Full Text] [Related]
12. Association of Methadone Treatment With Substance-Related Hospital Admissions Among a Population in Canada With a History of Criminal Convictions.
Russolillo A; Moniruzzaman A; Somers JM
JAMA Netw Open; 2019 Mar; 2(3):e190595. PubMed ID: 30874778
[TBL] [Abstract][Full Text] [Related]
13. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
[TBL] [Abstract][Full Text] [Related]
14. Proportional hazards frailty models for recurrent methadone maintenance treatment.
Nosyk B; MacNab YC; Sun H; Fischer B; Marsh DC; Schechter MT; Anis AH
Am J Epidemiol; 2009 Sep; 170(6):783-92. PubMed ID: 19671835
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome.
Saxon AJ; Wells EA; Fleming C; Jackson TR; Calsyn DA
Addiction; 1996 Aug; 91(8):1197-209. PubMed ID: 8828247
[TBL] [Abstract][Full Text] [Related]
16. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
[TBL] [Abstract][Full Text] [Related]
17. Treatment process and relapse to opioid use during methadone maintenance.
Joe GW; Simpson DD; Sells SB
Am J Drug Alcohol Abuse; 1994; 20(2):173-97. PubMed ID: 8042602
[TBL] [Abstract][Full Text] [Related]
18. Methadone medical maintenance in primary care. An implementation evaluation.
Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance: predictors of outcome in a Canadian milieu.
Lehmann F; Lauzon P; Amsel R
J Subst Abuse Treat; 1993; 10(1):85-9. PubMed ID: 8450579
[TBL] [Abstract][Full Text] [Related]
20. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
Bell J; Burrell T; Indig D; Gilmour S
Drug Alcohol Depend; 2006 Jan; 81(1):55-61. PubMed ID: 15993552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
